デフォルト表紙
市場調査レポート
商品コード
1458737

サンガーシーケンシングの世界市場レポート 2024年

Sanger Sequencing Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
サンガーシーケンシングの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

サンガーシーケンシング市場規模は、今後数年で急成長が見込まれます。2028年には年間平均成長率(CAGR)17.8%で53億米ドルに成長します。予測期間に予想される成長は、臨床ゲノミクスの統合の増加、農業ゲノミクスへの応用拡大、医薬品安全性と薬理ゲノミクスへの注目の高まり、出生前および新生児スクリーニングの利用増加、環境DNA分析の採用増加など、いくつかの要因によってもたらされます。この期間に予想される主な動向には、技術の進歩、次世代シーケンシング技術に対する需要の高まり、臨床診断への応用拡大、ゲノミクス研究への投資の増加、個別化医療におけるゲノミクスの利用拡大などがあります。

予測される遺伝性疾患の増加は、当面のサンガーシーケンシング市場拡大の原動力となると思われます。遺伝性疾患(遺伝性障害)は、遺伝情報を担う遺伝物質である個人のDNAの異常や変異に起因します。サンガーシーケンシングは、特定の遺伝子やDNA領域内のヌクレオチド(DNAの構成要素)の配列を正確に決定することで、遺伝病の診断に重要な役割を果たしています。例えば、米国の政府機関である遺伝性希少疾患情報センター(GARD)のデータでは、2024年2月までに約7,000の既知の希少遺伝病が明らかになり、2020年から2021年の間に、米国の約10人に1人、約3,000万人が罹患しています。その結果、遺伝性疾患の急増がサンガーシーケンシング市場の成長を促進するカタリストとして機能しています。

サンガーシーケンシング市場の主要プレーヤーは、収益成長を促進するために先進システムの開発に投資しています。これらの先進的なシステムは、より高いスループットに対応するように設計されており、複数のサンプルの同時処理を可能にしています。例えば、米国を拠点とする酵素および関連製品の専門メーカーであるプロメガ・コーポレーションは、2021年10月にProDye Terminator Sequencing Systemを発表しました。このシステムは、コンパクトなベンチトップのSpectrum Compact CEシステムを含む、すべてのキャピラリー電気泳動(CE)プラットフォームに対応しています。このシステムにより、研究室はどのCE装置でも、さまざまな規模の研究室に対応したサンガーシーケンシングを実施することができます。独自の耐熱性DNAポリメラーゼを活用したProDye Terminatorシーケンスシステムは、Spectrum Compact CEシステム、SeqStudio Genetic Analyzers、Applied Biosystems Genetic Analyzersなど、さまざまな機器に導入できます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界のサンガーシーケンシング市場、シーケンシング別セグメンテーション、実績および予測、2018年~2023年、2023年~2028年、2033年
  • ショットガンシーケンス
  • 標的遺伝子配列決定
  • その他のシーケンス
  • 世界のサンガーシーケンシング市場、ラボ別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • ウェットラボ
  • ドライラボ
  • 世界のサンガーシーケンシング市場、調査別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • 社内
  • アウトソーシング
  • 世界のサンガーシーケンシング市場、アプリケーション別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • 診断
  • バイオマーカーとがん
  • リプロダクティブ・ヘルス
  • 個別化医療
  • 法医学
  • その他のアプリケーション
  • 世界のサンガーシーケンシング市場、エンドユーザー別セグメンテーション、実績および予測、2018~2023年、2023~2028年、2033年
  • 学術
  • 政府研究機関
  • 製薬会社
  • バイオテクノロジー企業
  • 病院
  • クリニック

第7章 地域別・国別分析

  • 世界のサンガーシーケンシング市場、地域別、実績および予測、2018~2023年、2023~2028年、2033年
  • 世界のサンガーシーケンシング市場、国別、実績および予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • サンガーシーケンシング市場の競合情勢
  • サンガーシーケンシング市場の企業プロファイル
    • Hoffmann-La Roche
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Eurofins Scientific
    • Illumina Inc.

第31章 その他の大手企業と革新的企業

  • Beckman Coulter
  • PerkinElmer Inc.
  • BGI Group
  • LGC Limited
  • GenScript
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • Macrogen Inc.
  • GENEWIZ Inc.
  • Quintara Biosciences
  • CeMIA SA
  • Source BioScience
  • Microsynth AG
  • Fasteris SA
  • GenHunter Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的分析

第36章 付録

目次
Product Code: r16719

Sanger sequencing, also known as chain termination sequencing, is a technique utilized to determine the nucleotide sequence of DNA. It finds application in smaller-scale projects and validating the results of deep sequencing, producing DNA sequence reads exceeding 500 nucleotides while maintaining high accuracy levels.

Sanger sequencing encompasses several types, including shotgun sequencing, targeted gene sequencing, and others. In shotgun sequencing, random fragments of a lengthy DNA molecule are sequenced in parallel and then pieced together using their overlapping segments. Laboratories employing Sanger sequencing methods can be categorized as wet labs or dry labs, while research endeavors can be conducted in-house or outsourced. These techniques are employed across various applications such as diagnostics, biomarkers, cancer research, reproductive health, personalized medicine, forensics, among others. Moreover, Sanger sequencing serves a diverse range of end-users including academic institutions, government research institutes, pharmaceutical companies, biotechnology firms, hospitals, and clinics.

The sanger sequencing market research report is one of a series of new reports from The Business Research Company that provides sanger sequencing market statistics, including sanger sequencing industry global market size, regional shares, competitors with a sanger sequencing market share, detailed sanger sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the sanger sequencing industry. This sanger sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.29 billion in 2023 to $2.75 billion in 2024 at a compound annual growth rate (CAGR) of 19.9%. The growth observed during the historical period can be attributed to several factors, including heightened demand for research, expanding applications in medical diagnostics, growing pharmaceutical development activities, increased utilization in agriculture, rising demand for forensic analysis, enhanced discovery of biomarkers, and growing studies in genetic evolution.

The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.30 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%. The growth anticipated in the forecast period is driven by several factors, including the increasing integration of clinical genomics, expanded applications in agricultural genomics, heightened focus on drug safety and pharmacogenomics, rising utilization of prenatal and newborn screening, and increased adoption of environmental DNA analysis. Major trends expected during this period include technological advancements, a growing demand for next-generation sequencing technologies, expanding applications in clinical diagnostics, increased investments in genomics research, and the widening use of genomics in personalized medicine.

The projected increase in genetic illnesses is set to drive the expansion of the Sanger sequencing market in the foreseeable future. Genetic illnesses, or genetic disorders, stem from abnormalities or mutations in an individual's DNA, the genetic material responsible for carrying hereditary information. Sanger sequencing plays a crucial role in diagnosing genetic illnesses by precisely determining the sequence of nucleotides (the DNA building blocks) within a specific gene or DNA region. For instance, data from the Genetic Rare Diseases Information Center (GARD), a US-based government agency, revealed approximately 7,000 known rare genetic diseases by February 2024, affecting approximately 1 in 10 individuals or around 30 million people in the United States during 2020-2021. Consequently, the surge in genetic illnesses acts as a catalyst propelling the growth of the Sanger sequencing market.

Major players within the Sanger sequencing market are investing in the development of advanced systems to drive revenue growth. These advanced systems are engineered to accommodate higher throughput, enabling the simultaneous processing of multiple samples. For example, in October 2021, Promega Corporation, a US-based manufacturer specializing in enzymes and related products, introduced the ProDye Terminator Sequencing System. This system is compatible with all capillary electrophoresis (CE) platforms, including the compact benchtop Spectrum Compact CE System. It enables research laboratories to conduct Sanger sequencing on any CE instrument, catering to a range of laboratory sizes. Leveraging a proprietary thermostable DNA polymerase, the ProDye Terminator Sequencing System can be deployed on various instruments such as the Spectrum Compact CE System, SeqStudio Genetic Analyzers, and Applied Biosystems Genetic Analyzers.

In January 2023, Qiagen, a German company specializing in sample and assay technologies, acquired Verogen for $150 million. This strategic move enables Qiagen to optimize its renowned sample extraction and library preparation automation capabilities, thereby bolstering the channel reach and market presence of both companies in support of the forensic market. Verogen, based in the United States, is a leading provider of Sanger sequencing solutions tailored for human identification and forensic laboratories.

Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

North America was the largest region in the sanger sequencing market in 2023. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sanger sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sanger Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sanger sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sanger sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sanger sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Sequencing: Shotgun Sequencing; Targeted Gene Sequencing; Other Sequencing
  • 2) By Laboratory: Wet Labs; Dry Labs
  • 3) By Research: In-House; Outsourced
  • 4) By Application: Diagnostics; Biomarkers and Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications
  • 5) By End User: Academic; Government Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Hospitals; Clinics
  • Companies Mentioned: Hoffmann-La Roche; Thermo Fisher Scientific Inc.; Merck KGaA; Eurofins Scientific; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sanger Sequencing Market Characteristics

3. Sanger Sequencing Market Trends And Strategies

4. Sanger Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Sanger Sequencing Market Size and Growth

  • 5.1. Global Sanger Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Sanger Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Sanger Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sanger Sequencing Market Segmentation

  • 6.1. Global Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • Other Sequencing
  • 6.2. Global Sanger Sequencing Market, Segmentation By Laboratory, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Wet Labs
  • Dry Labs
  • 6.3. Global Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In-House
  • Outsourced
  • 6.4. Global Sanger Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications
  • 6.5. Global Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic
  • Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals
  • Clinics

7. Sanger Sequencing Market Regional And Country Analysis

  • 7.1. Global Sanger Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Sanger Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sanger Sequencing Market

  • 8.1. Asia-Pacific Sanger Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sanger Sequencing Market

  • 9.1. China Sanger Sequencing Market Overview
  • 9.2. China Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sanger Sequencing Market

  • 10.1. India Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sanger Sequencing Market

  • 11.1. Japan Sanger Sequencing Market Overview
  • 11.2. Japan Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sanger Sequencing Market

  • 12.1. Australia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sanger Sequencing Market

  • 13.1. Indonesia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sanger Sequencing Market

  • 14.1. South Korea Sanger Sequencing Market Overview
  • 14.2. South Korea Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sanger Sequencing Market

  • 15.1. Western Europe Sanger Sequencing Market Overview
  • 15.2. Western Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sanger Sequencing Market

  • 16.1. UK Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sanger Sequencing Market

  • 17.1. Germany Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sanger Sequencing Market

  • 18.1. France Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sanger Sequencing Market

  • 19.1. Italy Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sanger Sequencing Market

  • 20.1. Spain Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sanger Sequencing Market

  • 21.1. Eastern Europe Sanger Sequencing Market Overview
  • 21.2. Eastern Europe Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sanger Sequencing Market

  • 22.1. Russia Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sanger Sequencing Market

  • 23.1. North America Sanger Sequencing Market Overview
  • 23.2. North America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sanger Sequencing Market

  • 24.1. USA Sanger Sequencing Market Overview
  • 24.2. USA Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sanger Sequencing Market

  • 25.1. Canada Sanger Sequencing Market Overview
  • 25.2. Canada Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sanger Sequencing Market

  • 26.1. South America Sanger Sequencing Market Overview
  • 26.2. South America Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sanger Sequencing Market

  • 27.1. Brazil Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sanger Sequencing Market

  • 28.1. Middle East Sanger Sequencing Market Overview
  • 28.2. Middle East Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sanger Sequencing Market

  • 29.1. Africa Sanger Sequencing Market Overview
  • 29.2. Africa Sanger Sequencing Market, Segmentation By Sequencing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Sanger Sequencing Market, Segmentation By Research, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Sanger Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sanger Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Sanger Sequencing Market Competitive Landscape
  • 30.2. Sanger Sequencing Market Company Profiles
    • 30.2.1. Hoffmann-La Roche
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Eurofins Scientific
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Illumina Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Sanger Sequencing Market Other Major And Innovative Companies

  • 31.1. Beckman Coulter
  • 31.2. PerkinElmer Inc.
  • 31.3. BGI Group
  • 31.4. LGC Limited
  • 31.5. GenScript
  • 31.6. Oxford Nanopore Technologies
  • 31.7. Pacific Biosciences of California Inc.
  • 31.8. Macrogen Inc.
  • 31.9. GENEWIZ Inc.
  • 31.10. Quintara Biosciences
  • 31.11. CeMIA SA
  • 31.12. Source BioScience
  • 31.13. Microsynth AG
  • 31.14. Fasteris SA
  • 31.15. GenHunter Corporation

32. Global Sanger Sequencing Market Competitive Benchmarking

33. Global Sanger Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sanger Sequencing Market

35. Sanger Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Sanger Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Sanger Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Sanger Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer